4.4 Long-term safety and off-target effects Emerging reports link GLP-1RAs to rare ocular adverse events, including NAION ( 5 Conclusion In conclusion, the expanding body of evidence supports that GLP-1RAs offer a multifaceted approach to ocular therapeutics by targeting key molecular pathways involved in retinal neuroprotection, mitochondrial regulation, inflammation, vascular remodeling, and angiogenesis
Expert Guidance: Ivologists providers have extensive experience in GLP-1 medications, ensuring that you receive well-rounded advice based on the latest clinical data
Neuroinflammation 9:270
Medical Benefit Explained: GLP-1 Coverage November 7, 2025 Updated March 11, 2026 50 min read Learn the key differences between pharmacy vs
Joint inflammation and osteoarthritis Research shows that people taking tirzepatide had a significantly lower risk of osteoarthritis compared to those using other medications, even after accounting for age and overall weight loss
Never throw used needles in the regular trash